These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 104018)

  • 1. Investigation of [18F]2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism.
    Phelps ME; Hoffman EJ; Selin C; Huang SC; Robinson G; MacDonald N; Schelbert H; Kuhl DE
    J Nucl Med; 1978 Dec; 19(12):1311-9. PubMed ID: 104018
    [No Abstract]   [Full Text] [Related]  

  • 2. [18F]-labeled 3-deoxy-3-fluoro-D-glucose: synthesis and preliminary biodistribution data.
    Tewson TJ; Welch MJ; Raichle ME
    J Nucl Med; 1978 Dec; 19(12):1339-45. PubMed ID: 104019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the [18F]fluorodeoxyglucose kinetic model in calculations of myocardial glucose metabolism during ischemia.
    Marshall RC; Huang SC; Nash WW; Phelps ME
    J Nucl Med; 1983 Nov; 24(11):1060-4. PubMed ID: 6631527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: The radiation dosimetry of 2-[F-18]fluoro-2-deoxy-D-glucose in man.
    Smith T
    J Nucl Med; 1983 May; 24(5):447-8. PubMed ID: 6842294
    [No Abstract]   [Full Text] [Related]  

  • 5. Application of the deoxyglucose method to human cerebral dysfunction. The use of [2-18F] fluoro-2-deoxy-D-glucose in man.
    Reivich M
    Neurosci Res Program Bull; 1976 Sep; 14(4):502-4. PubMed ID: 980261
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose.
    Gallagher BM; Fowler JS; Gutterson NI; MacGregor RR; Wan CN; Wolf AP
    J Nucl Med; 1978 Oct; 19(10):1154-61. PubMed ID: 214528
    [No Abstract]   [Full Text] [Related]  

  • 7. A new method using anhydrous [18F]fluoride to radiolabel 2-[18F]fluoro-2-deoxy-D-glucose.
    Levy S; Elmaleh DR; Livni E
    J Nucl Med; 1982 Oct; 23(10):918-22. PubMed ID: 7119887
    [No Abstract]   [Full Text] [Related]  

  • 8. Alternative formula for glucose utilization using labeled deoxyglucose.
    Brooks RA
    J Nucl Med; 1982 Jun; 23(6):538-9. PubMed ID: 7077405
    [No Abstract]   [Full Text] [Related]  

  • 9. F-19 MR imaging of glucose metabolism in the rabbit.
    Nakada T; Kwee IL; Griffey BV; Griffey RH
    Radiology; 1988 Sep; 168(3):823-5. PubMed ID: 3136509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged metabolic recovery allows late identification of ischemia in the absence of electrocardiographic and perfusion changes in patients with exertional angina.
    Camici P; Araujo L; Spinks T; Lammertsma AA; Sohanpal SK; Jones T; Maseri A
    Can J Cardiol; 1986 Jul; Suppl A():131A-135A. PubMed ID: 3489509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The deoxyglucose method: theory and practice.
    Sokoloff L
    Eur Neurol; 1981; 20(3):137-45. PubMed ID: 7262108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism.
    Ratib O; Phelps ME; Huang SC; Henze E; Selin CE; Schelbert HR
    J Nucl Med; 1982 Jul; 23(7):577-86. PubMed ID: 6979614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmural distribution of myocardial glucose utilization measured by 2-deoxy-14C-glucose.
    Flohr H; Breull W
    Bibl Anat; 1979; (18):243-5. PubMed ID: 496839
    [No Abstract]   [Full Text] [Related]  

  • 14. Measurement of glucose utilisation with [18F]2-fluoro-2-deoxy-D-glucose: a comparison of different analytical methods.
    Lammertsma AA; Brooks DJ; Frackowiak RS; Beaney RP; Herold S; Heather JD; Palmer AJ; Jones T
    J Cereb Blood Flow Metab; 1987 Apr; 7(2):161-72. PubMed ID: 3558499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiopharmaceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals.
    Gallagher BM; Ansari A; Atkins H; Casella V; Christman DR; Fowler JS; Ido T; MacGregor RR; Som P; Wan CN; Wolf AP; Kuhl DE; Reivich M
    J Nucl Med; 1977 Oct; 18(10):990-6. PubMed ID: 903484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of 3-deoxy-3-fluoro-D-glucose as a glucose transport analogue in rat heart.
    Halama JR; Gatley SJ; DeGrado TR; Bernstein DR; Ng CK; Holden JE
    Am J Physiol; 1984 Nov; 247(5 Pt 2):H754-9. PubMed ID: 6496756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary imaging results with 18F-2-fluoro-2-deoxy-D-glucose.
    Brownell GL; Ackerman RH; Strauss HW; Elmaleh DR; Cochavi S; Alpert N; Correia JA; Kearfott KJ; Taveras J
    J Comput Assist Tomogr; 1980 Aug; 4(4):473-7. PubMed ID: 6771307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 2- and 3-18F-fluoro-deoxy-D-glucose for studies of tissue metabolism.
    Kearfott KJ; Elmaleh DR; Goodman M; Correia JA; Alpert NM; Ackerman RH; Brownell GL; Strauss WH
    Int J Nucl Med Biol; 1984; 11(1):15-22. PubMed ID: 6610664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18f-fluorodeoxyglucose method for measuring local cerebral glucose metabolism in man: technique and results.
    Reivich M; Alavi A; Greenberg J; Farkas T; Wolf A
    Prog Nucl Med; 1981; 7():138-48. PubMed ID: 7323304
    [No Abstract]   [Full Text] [Related]  

  • 20. F-18-labeled 3-deoxy-3-fluoro-D-glucose for the study of regional metabolism in the brain and heart.
    Goodman MM; Elmaleh DR; Kearfott KJ; Ackerman RH; Hoop B; Brownell GL; Alpert NM; Strauss HW
    J Nucl Med; 1981 Feb; 22(2):138-44. PubMed ID: 6970254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.